Source / episode info
- **Episode:**402
- **Title:**Divine Intervention Episode 402 – Pulmonary Pathophysiology Series 4
- **Published:**2022-07-11
- Source:Episode page
One-liner
This episode provides a deep dive into pulmonary pathophysiology, covering the mechanisms of {AEIRD} (via leukotriene pathways), management of {CRSwNP}, treatment modalities for {PAH} (targeting endothelin and prostacyclin), and specific therapies for cystic fibrosis and allergic rhinitis.
High-yield summary
- Aspirin Exacerbated Respiratory Disease ({AEIRD}): Occurs when aspirin/NSAIDs block the COX pathway, shunting arachidonic acid metabolism to the LOX pathway, leading to excessive leukotriene production (e.g., {LTB}_4, a potent neutrophil chemoattractant), causing severe bronchospasm and inflammation.
- Chronic Rhinosinusitis with Nasal Polyps ({CRSwNP}): Often associated with asthma/atopy; treatment typically involves inhaled corticosteroids, as anti-histamines are often insufficient. {GPA} is another cause of nasal polyps.
- Pulmonary Hypertension ({PAH}): Pathophysiology involves vascular remodeling and vasoconstriction, frequently driven by mutations (e.g., BMPR2) or high levels of potent constrictors like Endothelin. Treatment targets these pathways using receptor antagonists (Bosentan, Unabosentan) or vasodilators ({PDE-5} inhibitors, Prostacyclin analogs).
- Cystic Fibrosis (CF): Characterized by thick mucus plugs due to defective mucin clearance. Therapies include agents that break down disulfide bonds (N-acetylcysteine) and phosphodiester bonds (Dornase alpha).
- Allergy Management: First-generation antihistamines are sedating because they cross the blood-brain barrier; second-generation antihistamines (e.g., Fexofenadine) are preferred for reduced sedation.
Learning objectives
- Describe the metabolic pathways (COX vs. LOX) involved in asthma exacerbation following NSAID use (\text{AEIRD}).
- Identify appropriate therapies for pulmonary hypertension, including specific drug targets (Endothelin/Prostacyclin).
- Differentiate between the management of \text{CRSwNP} and other causes of nasal polyps, recognizing the role of inhaled steroids.
- Explain the mechanism of action for mucolytic agents used in cystic fibrosis (\text{N}-acetylcysteine, Dornase alpha).
- Compare first-generation vs. second-generation antihistamines regarding central nervous system effects (sedation) and blood-brain barrier penetration.
Board exam buzzwords